Disease | chlamydia |
Comorbidity | C0242379|lung cancer |
Sentences | 1 |
PubMedID- 20501758 | Background: we evaluated the relationship of chlamydia pneumoniae infection with prospective lung cancer risk using traditional serologic markers [microimmunoflourescence (mif) igg and iga antibodies] and chlamydia heat shock protein-60 (chsp-60) antibodies, a marker for chronic chlamydial infection. |
Page: 1